World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 28 April 2013
Main ID:  NTR987
Date of registration: 04/06/2007
Primary sponsor: Erasmus Medical Center, department of Radiology
Public title: Vertebroplasty versus radiotherapy as palliative treatment of vertebral metastases of multiple myeloma (M. Kahler)
Scientific title: Vertebroplasty versus radiotherapy as palliative treatment of vertebral metastases of multiple myeloma (M. Kahler) - VERAMM
Date of first enrolment: 4/6/2007
Target sample size: 104
Recruitment status: recruiting
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=987
Study type:  intervention
Study design:  Randomised: Yes; Masking: None; Control: Active; Group: Parallel; Type: -  
Countries of recruitment
The Netherlands
Contacts
Name: P.M.T.   Pattynama
Address:  Department of Radiology Erasmus MC ?s-Gravendijkwal 230 3015 CE Rotterdam The Netherlands
Telephone: +31 10-4632886
Email: p.m.t.pattynama@erasmusmc.nl
Affiliation: 
Name:   Research Office, Erasmus MC Dept of Radiology
Address:  Research Office Erasmus MC Dept of Radiology ?s Gravendijkwal 230 3015 CE Rotterdam The Netherlands
Telephone: +31-10-463-2277
Email: research.radiology@erasmusmc.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Persistent pain caused by vertebral metastases from myeloma (including plasmacytoma) with VAS score >4 (scale: 1-10);
2. Informed consent;
3. Older than 18 years;

Exclusion criteria: 1. >4 affected vertebrae;
2. Vertebral fracture through back wall with retropulsion that consumes more than 33% of the spinal channel;
3. Myelum compression with neurological degeneration: Frankel A/B;
4. Epiduritis;
5. Incorrigible coagulopathy;
6. Karnofsky score <30 (moribund);


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Multiple myeloma (Kahler's disease), Vertebroplasty, Spinal metastases

Intervention(s)
Arm I (control):
radiotherapy (20 Gy) of affected vertebrae
Arm II:
vertebroplasty of affected vertebrae
Primary Outcome(s)
1. Degree of pain (VAS-pain score, scale: 0-10; pre-treatment and first 7 days post procedure);
2. Use of pain medication (pretreatment and day 0,day 7, week 4, week 12, month 6, year 1 after treatment)
Secondary Outcome(s)
1. Initial technical success & complications
Mobility (Oswestry-daily activity scale);
2. Quality of life (questionnaires:EORTC QLQ-MY24, SF-36);
3. Collapse of treated vertebrae (lateral X-WK)
4. Mortality
5. Direct medical costs (e.g. procedure costs, hospitalisation days, pain medication, secondary interventions, revalidation or nursing home costs, follow-up)
Secondary ID(s)
CCMO NL14746.078.07; Erasmus MC METC 2007-033
ISRCTN48083859
Source(s) of Monetary Support
Erasmus Medical Center, department of Radiology
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history